Parkinson's News Today Home | Parkinson's News Today
5 days ago · Aerobic exercise may help Parkinson’s patients after DBS. Aerobic exercise may help relieve non-motor symptoms of Parkinson’s disease in people who have undergone deep brain stimulation (DBS), a small study suggested.
Parkinson's News -- ScienceDaily
4 days ago · Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
New Parkinson’s drug could slow or reverse progression of …
Aug 21, 2024 · “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is a long way to go for development of this treatment,” Michael S. Okun, M.D., Parkinson’s Foundation medical adviser and director at the Norman Fixel Institute for ...
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment...
FDA Approves New Treatment for Advanced Parkinson’s Disease
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help...
Parkinson's disease - Latest research and news - Nature
4 days ago · Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
Parkinson's vaccine seen to target toxic protein in Phase 1 trial
Mar 11, 2024 · Treatment with UB-312, a vaccine designed to trigger an immune response against toxic clumps of the alpha-synuclein protein, reduced these damaging aggregations in people with Parkinson’s disease in a Phase 1 trial.
New Vaccine for Parkinson’s Moves Closer to 1st Human Trials
Dec 1, 2022 · An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to Parkinson’s disease and dementia with Lewy bodies (DLB) — is moving into late-stage preclinical research aimed at supporting future requests to test it in clinical trials.
New Findings About Key Pathological Protein in Parkinson’s …
Dec 18, 2023 · A so-called pathological protein long associated with Parkinson’s disease has been found in a new study to trigger cells to increase protein synthesis, an event that eventually kills the subset of brain cells that die off in this neurodegenerative condition.
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
Mar 11, 2024 · A novel therapy designed to clear toxic clumps of a protein thought to be responsible for Parkinson's disease has shown promise in early clinical trials.